<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35120">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01858220</url>
  </required_header>
  <id_info>
    <org_study_id>Sheba-9180-2011</org_study_id>
    <nct_id>NCT01858220</nct_id>
  </id_info>
  <brief_title>IS There a Correlation Between Sypmtoms of Gastroparesis and the Duration of Video Caspule Retention in the Stomach</brief_title>
  <official_title>Open Prospective Single Center Study for the Determination of Correlation Between Video Capsule Period of Retention in the Stomach and Symptoms of Gastroparesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastroparesis is a syndrome characterized by delayed gastric emptying in absence of
      mechanical obstruction of the stomach. The cardinal symptoms include postprandial fullness
      (early satiety), nausea, vomiting, and bloating.Capsule endoscopy (CE) has evolved to become
      a first-line, noninvasive diagnostic technique for the small bowel. CE is now being utilized
      to assess patients for obscure gastrointestinal bleeding, possible Crohn's disease, celiac
      disease and small bowel tumors. Capsule endoscopy is preformed in a fasting state, and
      usually past the pylorus of the stomach into the duodenum after up to 30-40 minutes. The aim
      of the study is to determine the correlation between gasytoparesis symptoms to duration of
      capsule retention in the stomach
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Duration of capsule retention in the stomach</measure>
    <time_frame>End of capsule examination</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Gastroparesis</condition>
  <arm_group>
    <arm_group_label>Video capsule examinee</arm_group_label>
    <description>Every subject having capsule endoscopy for any indication</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Any patient undergoing small bowel video capsule examination for any indication
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Undergoing video capsule endoscopy for any indication

        Exclusion Criteria:

        -Endoscopic intraduodenal insertion of the capsule -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dan Carter, MD</last_name>
    <phone>972-3-5302197</phone>
    <email>carterd@zahav.net.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Carter, MD</last_name>
      <phone>972-3-5302197</phone>
      <email>carterd@zahav.net.il</email>
    </contact>
    <investigator>
      <last_name>Dan Carter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eytan Bardan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 24, 2014</lastchanged_date>
  <firstreceived_date>May 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Dr. Dan Carter, Gastroenterologist</investigator_full_name>
    <investigator_title>Senior GI Consult</investigator_title>
  </responsible_party>
  <keyword>Gastroparesis</keyword>
  <keyword>Small bowel video capsule</keyword>
  <keyword>gastric retention</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
